Independent Analysis Addresses Common Consumer Questions Including Legitimacy, Safety Considerations, Pricing Transparency, ...
Trump has sparred with Colorado leaders over the imprisonment of his political ally, former Mesa County elections clerk Tina ...
Health system pharmacists and clinicians are monitoring a wave of drug approvals expected throughout 2026, including first-in-class therapies and expanded uses of existing drugs with implications for ...
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including ...
Parent Company of Doctor's Best Secures Coveted NDI Letter for NMN Supplement Sales TUSTIN, Calif., Jan. 7, 2026 /PRNewswire/ -- Doctor's Best, a leading nutritional supplement company, announces that ...
By the end of March, the agency could approve multiple “national priority” voucher winners, as well as a gene therapy it ...
Just in time for the holidays, on December 15, 2025, the U.S. Food and Drug Administration (“FDA”) Office of Prescription Drug Promotion (“OPDP”) issued an untitled letter (the “Letter”) to Karuna ...
News-Medical.Net on MSN
Individualized drug combinations improve cancer treatment outcomes
Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show that cancer drug treatments can be safely and effectively personalized based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback